Upload folder using huggingface_hub

checkpoints/ner_phase7_cohort_study/clf_best/config.json

@@ -0,0 +1,36 @@
+{
+  "add_cross_attention": false,
+  "architectures": [
+    "BertForSequenceClassification"
+  ],
+  "attention_probs_dropout_prob": 0.1,
+  "bos_token_id": null,
+  "classifier_dropout": null,
+  "dtype": "float32",
+  "eos_token_id": null,
+  "hidden_act": "gelu",
+  "hidden_dropout_prob": 0.1,
+  "hidden_size": 768,
+  "id2label": {
+    "0": "no_adr",
+    "1": "contains_adr"
+  },
+  "initializer_range": 0.02,
+  "intermediate_size": 3072,
+  "is_decoder": false,
+  "label2id": {
+    "contains_adr": 1,
+    "no_adr": 0
+  },
+  "layer_norm_eps": 1e-12,
+  "max_position_embeddings": 512,
+  "model_type": "bert",
+  "num_attention_heads": 12,
+  "num_hidden_layers": 12,
+  "pad_token_id": 0,
+  "tie_word_embeddings": true,
+  "transformers_version": "5.9.0",
+  "type_vocab_size": 2,
+  "use_cache": false,
+  "vocab_size": 30522
+}

checkpoints/ner_phase7_cohort_study/clf_best/model.safetensors

@@ -0,0 +1,3 @@
+version https://git-lfs.github.com/spec/v1
+oid sha256:2c5c03f24c9608b31df7f84182aac9d9c104253203011d55ad0f71cc0c5c161f
+size 437958648

checkpoints/ner_phase7_cohort_study/clf_best/tokenizer_config.json

@@ -0,0 +1,22 @@
+{
+  "backend": "tokenizers",
+  "cls_token": "[CLS]",
+  "do_lower_case": true,
+  "is_local": true,
+  "local_files_only": false,
+  "mask_token": "[MASK]",
+  "max_length": 128,
+  "model_max_length": 1000000000000000019884624838656,
+  "pad_to_multiple_of": null,
+  "pad_token": "[PAD]",
+  "pad_token_type_id": 0,
+  "padding_side": "right",
+  "sep_token": "[SEP]",
+  "stride": 0,
+  "strip_accents": null,
+  "tokenize_chinese_chars": true,
+  "tokenizer_class": "BertTokenizer",
+  "truncation_side": "right",
+  "truncation_strategy": "longest_first",
+  "unk_token": "[UNK]"
+}

checkpoints/ner_phase7_cohort_study/cls_val.jsonl

@@ -0,0 +1,46 @@
+{"id": "954aa74eadbf", "text": "The temporal assessment of an ADR is illustrated by a quote: “The way I was before I visited the hospital, it has become over (after taking the medicine).” [Participant 11: female, no education].Only one participant assessed an ADR with the help of a family member.", "label": 1, "source_type": "qualitative_interview"}
+{"id": "a145da3c7c61", "text": "A 38-year old health worker had this to say on the issue:“Well, some patients vomit and there is dizziness as well, but it is the dizziness and the vomiting that I have heard a lot of people complained about.", "label": 1, "source_type": "qualitative_interview"}
+{"id": "31334088b6d7", "text": "In this study however, views expressed are slightly different because most patients attributed all the side effects to the use of artesunate-amodiaquine compared to other combinations.According to Asante et al., side effects such as headache, inability for some patients to control the neck and tongue were reported by patients who used ACT [5].", "label": 1, "source_type": "qualitative_interview"}
+{"id": "3bfce90f3beb", "text": "This will encourage patients who experience side effects to report them.", "label": 0, "source_type": "qualitative_interview"}
+{"id": "85737ddb20cb", "text": "Patients perceived such side effects as normal and reporting them held no relevance to them.", "label": 0, "source_type": "qualitative_interview"}
+{"id": "590bfb302940", "text": "They added that poly-pharmacy was common within the health system and that drug interaction was more likely to cause some of the side effects that the patients complain about.", "label": 0, "source_type": "qualitative_interview"}
+{"id": "719820e3cdff", "text": "They were particularly concerned about overdosing of medications, including ACT, by some patients as a contributor to these side effects.“The other reason is that they think that when they take overdose it will help to cure the illness fast and this makes them get the side effect.", "label": 0, "source_type": "qualitative_interview"}
+{"id": "6518fc1325ac", "text": "We got this experience from our father who died of malaria” (IDI: 32-year old female patient).Similar views were shared by health professionals and chemical shop owners on the side effects patients with malaria experience from using ACT.", "label": 0, "source_type": "qualitative_interview"}
+{"id": "9c15791b5ed2", "text": "They were particularly concerned about overdosing by some patients.In Ghana, the policy is that all patients are supposed to be well informed by prescribers and pharmacists on the possible side effect they are likely to experience from the use of ACT and the need for them to report.", "label": 0, "source_type": "qualitative_interview"}
+{"id": "1b83bb52b148", "text": "These side effects have not been reported in this study.", "label": 0, "source_type": "qualitative_interview"}
+{"id": "5f5cf273de2a", "text": "It is possible that these differences in views on the side effects on the use of ACT could be as a result of differences in individual human system.Patients are supposed to eat very well before using these medications.", "label": 0, "source_type": "qualitative_interview"}
+{"id": "3e0bbeefe10e", "text": "ConclusionThe key factors responsible for the inability of patients to report side effects from using ACT are lack of health education, attitude of some patients and the unpleasant behaviour of some health workers towards patients at the health facilities.", "label": 0, "source_type": "qualitative_interview"}
+{"id": "a0b0cc7b5c67", "text": "The management of drug-induced oculogyric crisis includes discontinuation or, if not possible, reducing the dose of the opposing agent.", "label": 0, "source_type": "case_report"}
+{"id": "b57fb2e1f129", "text": "The mainstay treatment for oculogyric crisis is anticholinergics [6].", "label": 0, "source_type": "case_report"}
+{"id": "55d69c97098a", "text": "His urine output for the first 24 hours was 100mls but he was not in pulmonary oedema.On day 2 of admission, his daily IV fluid input was increased to 3.5L in 24 hours.", "label": 0, "source_type": "case_report"}
+{"id": "92526e3c1933", "text": "Therefore, the aim of this case report is bring to fore the association of AL as a cause of drug-induced oculogyric crisis.", "label": 1, "source_type": "case_report"}
+{"id": "ba30728895eb", "text": "The symptoms of oculogyric crisis significantly improved 1 h after the IM injection.", "label": 1, "source_type": "case_report"}
+{"id": "e1f79cf2556d", "text": "Common side effects include muscle and joint pain, fever, loss of appetite, and headache.", "label": 1, "source_type": "case_report"}
+{"id": "a1b02f8dec2f", "text": "Two days prior to presentation at our facility, he visited a pharmacy with complaints of fever measuring 37.9 °C, general body pains, and weakness.", "label": 1, "source_type": "case_report"}
+{"id": "06ff19b3c0aa", "text": "V, 2333 CN Leiden, The Netherlands 2°C - 8°C Moderna’s Dispersion for Injection [COVID-19 mRNA Vaccine (nucleoside modified)] Moderna Biotech Spain, S.L. -25°C - 15°C Comirnaty Concentrate for Dispersion for Injection [COVID-19 mRNA Vaccine (nucleoside modified)] BioNTech Manufacturing GmbH, Germany -80°C - 60°C (6months) and 2°C to 8°C up to 5days COVID-19 Vaccine AstraZeneca Suspension for Injection (ChAdOx1 S [recombinant]) AstraZeneca, United Kingdom 2°C - 8°C The FDA has granted Emergency Use Authorization (EUA) to six COVID-19 vaccines on the dates indicated below at the time of publication of this newsletter.", "label": 0, "source_type": "fda_newsletter"}
+{"id": "53453fa9be8a", "text": "DrugLens Issue 7 NO MAH NAME OF DRUG ACTIVE INGREDIENT INDICATION 6 7 GSK GSK Nepine SR 20mg tablets Ventolin Rotacaps 200mcg Nifedipine SR 20mg Ventolin Rotacaps 200mcg Treatment of hypertension (high blood pressure) and angina (chest pain).", "label": 0, "source_type": "fda_newsletter"}
+{"id": "2785b98ef517", "text": "The MHRA recommended that patients with underlying cardiac conditions who are administered Hyoscine butylbromide injection should be monitored.", "label": 0, "source_type": "fda_newsletter"}
+{"id": "a19cece34324", "text": "DrugLens Issue 7 NO MAH NAME OF DRUG ACTIVE INGREDIENT INDICATION 18 GSK Seretide Evohaler 25/125mcg and 25/50mcg Inhaler Fluticasone propionate/ Salmeterol Treatment of asthma where use of a combination product (longacting β2 agonist and inhaled corticosteroid) is appropriate and for the symptomatic treatment of patients with COPD, with a FEV1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy 19 GSK Xylal 5mg Tablets Levocetirizine Hydrochloride Symptomatic treatment of allergic rhinitis (including persistent allergic rhinitis) and urticaria in adults and children aged 6 years and above GHANA Your Well-being, Our Priority. 15", "label": 0, "source_type": "fda_newsletter"}
+{"id": "27f23912e574", "text": "New safety information or signals identified by FDA through the adverse reaction reporting system in 2021 SAFETY COMMUNICATIONS PUBLISHED BETWEEN JANUARY 2021 TO JUNE 2022 Contamination of Losartan Active Substance with Mutagenic Azido Impurities This publication sought to bring to the attention of the general public information from European health authorities about detection of previously unknown Azido impurity, 4-chlorazidomethyltetrazole in some sartan medicines.", "label": 0, "source_type": "fda_newsletter"}
+{"id": "9ab528caff6c", "text": "From March to August 2021, three vaccines namely, Oxford/AstraZeneca (Covishield/Vaxzevria), Sputnik V and COVID-19 Vaccine Janssen (Johnson and Johnson vaccine) had been deployed in Ghana.", "label": 0, "source_type": "fda_newsletter"}
+{"id": "c6448f35e9e3", "text": "She had to travel on a number of occasions from Peki to the FDA Regional Office in Ho to pick up adverse reaction reporting forms when none was available in her institution.", "label": 0, "source_type": "fda_newsletter"}
+{"id": "2a738f5c7200", "text": "7 DRUGLENS ISSUE 5 Hyoscine butylbromide (Buscopan) is indicated for acute muscular spasm including renal or biliary colic, in radiology for differential diagnosis of obstruction and to reduce spasm and pain in pyelography, and in other diagnostic procedures where spasm may be a problem.", "label": 0, "source_type": "fda_newsletter"}
+{"id": "e1f27d315b6c", "text": "DrugLens Newsletter 11 Figure 10: Outcome of causality assessment of RTS,S serious AEFI reports, Ghana, 1st May 2019 – 31st May 2022 Ghana has been deploying COVID-19 vaccines since March 2021 and as of 31st May 2022, approximately 15,496,852 doses of the five vaccine types (AstraZeneca COVID-19 Vaccine, COVID-19 vaccine Janssen, Moderna COVID-19 vaccine, Pfizer BioNTech COVID-19 vaccine and Sputnik V) have been administered to various segments of the target population.", "label": 0, "source_type": "fda_newsletter"}
+{"id": "bc00a72f6869", "text": "There were 3,365 AEFI reports submitted for Oxford/AstraZeneca (Covishield/Vaxzevria), 1,993 for Sputnik V and 93 for COVID-19 Vaccine Janssen.", "label": 0, "source_type": "fda_newsletter"}
+{"id": "e4e52541f0b4", "text": "Hydrochlorothiazide-containing medicines are used to treat hypertension, as well as cardiac and hepatic oedema, or chronic heart insufficiency.", "label": 0, "source_type": "fda_newsletter"}
+{"id": "1e9dcdf14f51", "text": "Studies have suggested that anaphylaxis is more likely to be fatal in patients with underlying coronary heart disease compared with those without.", "label": 1, "source_type": "fda_newsletter"}
+{"id": "694cb9a8ccf6", "text": "Tis publication sought to update healthcare professionals on a publication in the 2017 edition of the Druglens on the safety information relating to reports published by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) of acute myocardial infarction or cardiac arrest with fatal outcomes associated with the use of hyoscine butylbromide injection.", "label": 1, "source_type": "fda_newsletter"}
+{"id": "f6deaf7276dd", "text": "Cardiac symptoms reported include restlessness, sudden collapse with hypovolemic shock and sweating with cold peripheries.", "label": 1, "source_type": "fda_newsletter"}
+{"id": "e90188e5ec35", "text": "Newly reported ADRs of interest were one report each of tremor for doxycycline; scrotal pain, dyspnoea, gait disturbances and dysgeusia for chloroquine; and dry throat, hyperhidrosis, restlessness and micturition frequency increased for hydroxychloroquine.", "label": 1, "source_type": "fda_newsletter"}
+{"id": "8e5cbb21f74f", "text": "Guideline on Reporting Adverse Drug Reactions FDA/SMD/GDL - 01/05 Page 8 of 28 Drug abuse is a persistent or sporadic, intentional excessive use of medicines, which is accompanied by a harmful physical or psychological effect. “Expedited Reporting” This is the immediate reporting and in not more than 7 calendar days of a serious adverse reaction to the Authority. “Food supplements” Concentrated sources of nutrients or other substances produced in a pharmaceutical dosage form such as tablets, gelatin capsules (soft or hard), sachets, syrups and powders.", "label": 0, "source_type": "fda_guideline"}
+{"id": "cbde4b926718", "text": "The original words/description (verbatim) used by the initial reporter to describe the adverse reaction should be provided.", "label": 0, "source_type": "fda_guideline"}
+{"id": "987bca8d6fb9", "text": "Guideline on Reporting Adverse Drug Reactions FDA/SMD/GDL - 01/05 Page 23 of 28 4.4 Feedback on Reports Received 4.4.1 Adverse Reaction Reports The FDA shall acknowledge receipt of the adverse reaction report within 14 days of receipt.", "label": 0, "source_type": "fda_guideline"}
+{"id": "33dea22e8346", "text": "Internet or Digital media under the management of MAH should be screened regularly for adverse reaction reports and report to the Authority within the specified timelines.", "label": 0, "source_type": "fda_guideline"}
+{"id": "1233426000c5", "text": "It is very important that follow up reports are identified and linked to the original report. 3.1.7 Reporting During Clinical Trials For safety reporting in clinical trials, please refer to the Food and Drugs Authority’s Guidelines for Authorization of Clinical Trials of Medicines, Food Supplements, Vaccines and Medical Devices in Ghana (FDA/SMC/CTD/GL-ACT/2013/01). 3.1.8 Duplication of Report If the Local Representative Marketing Authorization Holder is aware that a person has reported a reaction of one of its products directly to the Food and Drugs Authority: The Local Representative or Manufacturer/ Marketing Authorization Holder should still report the adverse reaction informing the Authority that the report is a duplicate of a previous report.", "label": 1, "source_type": "fda_guideline"}
+{"id": "d3576317b790", "text": "Five potential safety concerns were identified under the period under review: anaemia (5 reports), jaundice (4 reports), aggression (2 reports), difficulty breathing (2 reports), and thigh pain (1 report).", "label": 1, "source_type": "fda_annual_report"}
+{"id": "5b5212f9be76", "text": "Healthcare professionals were informed about various issues, including the risk of anesthesia in individuals exposed to Pholcodine within 12 months before using neuromuscular blocking agents, the recall of Lupin's Quinapril Hydrochloride Tablets, enhanced risk management for Sodium valproate requiring changes to product information, and the detection of falsified Meronem IV in the Ghanaian market. 10,214 5,191 1,172 2,821 4,264 1,601 1,642 2,807 1,098 -42% -34% -31% ICSRs RECEIVED ICSRs ENTERED IN THE SWS ICSRs with CAUSALITY ASSESSMENT TRIAGED- TAC 2021 2022 2023 % DIFF BETWEEN 2023 & 2022", "label": 0, "source_type": "fda_annual_report"}
+{"id": "bad884bce3fd", "text": "The Minister of Health, Ghana, eventually issued an instruction through Executive Instrument 167 for the restriction of importation, manufacturer and registration of codeine-containing cough syrups [27].", "label": 0, "source_type": "surveillance_evaluation"}
+{"id": "81d68b77c1b6", "text": "Patients report to healthcare professionals (primary reporters) of any untoward experience after taking a medicine; the details of the experience are verified and recorded on the reporting form (BlueForm®) as suspected ADR.", "label": 0, "source_type": "surveillance_evaluation"}
+{"id": "be5f547e9f25", "text": "The 1,188 reports came from Public Health Programs (PHPs) such as School Deworming Program, the Girls Iron-Folate Tablet Supplementation (GIFTS) Programme and Ivermectin Mass Drug Administration.10.1371/journal.pone.0291482.g002Fig 2ADRs reported to NPC per year vs those not reported to NPC.Fig 3 shows the ADR reporting rate per million population for both Ho Municipal and the national data for the period of evaluation.", "label": 0, "source_type": "surveillance_evaluation"}
+{"id": "50aedb88ba9b", "text": "Sensitivity was also assessed by looking at the number of signals detected by the surveillance system.Predictive value positive was assessed using the number of case investigations completed and the proportion of confirmed ADRs (classified as “certain”) after causality assessment.", "label": 0, "source_type": "surveillance_evaluation"}
+{"id": "8621f5e1ee52", "text": "Major side effects of codeine use such as bloating, blurred vision, chills, confusion, darkened urine, shortness of breath, difficulty in breathing, weak pulse, the feeling of warmth, fever, indigestion, and loss of appetite had been reported.", "label": 1, "source_type": "surveillance_evaluation"}

checkpoints/ner_phase7_cohort_study/ner_best/config.json

@@ -0,0 +1,50 @@
+{
+  "add_cross_attention": false,
+  "architectures": [
+    "BertForTokenClassification"
+  ],
+  "attention_probs_dropout_prob": 0.1,
+  "bos_token_id": null,
+  "classifier_dropout": null,
+  "dtype": "float32",
+  "eos_token_id": null,
+  "hidden_act": "gelu",
+  "hidden_dropout_prob": 0.1,
+  "hidden_size": 768,
+  "id2label": {
+    "0": "O",
+    "1": "B-DRUG",
+    "2": "I-DRUG",
+    "3": "B-ADR",
+    "4": "I-ADR",
+    "5": "B-SEVERITY",
+    "6": "I-SEVERITY",
+    "7": "B-PATIENT_DEMO",
+    "8": "I-PATIENT_DEMO"
+  },
+  "initializer_range": 0.02,
+  "intermediate_size": 3072,
+  "is_decoder": false,
+  "label2id": {
+    "B-ADR": 3,
+    "B-DRUG": 1,
+    "B-PATIENT_DEMO": 7,
+    "B-SEVERITY": 5,
+    "I-ADR": 4,
+    "I-DRUG": 2,
+    "I-PATIENT_DEMO": 8,
+    "I-SEVERITY": 6,
+    "O": 0
+  },
+  "layer_norm_eps": 1e-12,
+  "max_position_embeddings": 512,
+  "model_type": "bert",
+  "num_attention_heads": 12,
+  "num_hidden_layers": 12,
+  "pad_token_id": 0,
+  "tie_word_embeddings": true,
+  "transformers_version": "5.9.0",
+  "type_vocab_size": 2,
+  "use_cache": false,
+  "vocab_size": 30522
+}

checkpoints/ner_phase7_cohort_study/ner_best/model.safetensors

@@ -0,0 +1,3 @@
+version https://git-lfs.github.com/spec/v1
+oid sha256:316a667ffd3b09a1d63d98c5af36d1dde615d9e4992cc3db527b6fb4e6d99f9f
+size 435617620

checkpoints/ner_phase7_cohort_study/ner_val.jsonl

@@ -0,0 +1,43 @@
+{"id": "97d2bdd4d7af", "text": "It is demonstrated that poor noncompliance to guidelines to the use of medications accounted for drug side effects [15].", "entities": [], "input_ids": [2, 2176, 1977, 3161, 1988, 3930, 22849, 2030, 8195, 1942, 5522, 1942, 1920, 2485, 1927, 7719, 9448, 1958, 2838, 4159, 2564, 37, 2461, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
+{"id": "0b8a120dbaa0", "text": "ADR = adverse drug reaction, HCW = health care workerThe way patients discover ADRs (Discovery) and reasons why they act when experiencing an ADR (Action) were two themes within the conceptual framework based on earlier studies [17, 18, 21, 23].", "entities": [], "input_ids": [2, 17645, 33, 5246, 2838, 3227, 16, 4387, 1018, 33, 2436, 2859, 16187, 20536, 4222, 2132, 5079, 28863, 12, 7139, 13, 1930, 6662, 7348, 2611, 4033, 2469, 12511, 1925, 17645, 12, 4615, 13, 1985, 2288, 12181, 2651, 1920, 9829, 6465, 2454, 1990, 5556, 2351, 37, 2752, 16, 2654, 16, 2900, 16, 3020, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
+{"id": "c7f2fa273f3f", "text": "A 46-year old pharmacist shared his views this way on the issue:“Yes there is a procedure and what usually happens is that there is an institutional contact person that is the pharmacist, who is supposed to compile all the side effects people come to complain about.", "entities": [{"start": 1, "end": 24, "label": "PATIENT_DEMO", "text": "46-year old pharmacist"}], "input_ids": [2, 43, 4182, 17, 2476, 4156, 23400, 7115, 4167, 9792, 2052, 4222, 1990, 1920, 6972, 30, 236, 11633, 2276, 1977, 43, 4360, 1930, 4663, 5394, 20686, 1977, 1988, 2276, 1977, 1925, 6540, 5217, 5952, 1988, 1977, 1920, 23400, 16, 2746, 1977, 18310, 1942, 2059, 2383, 2136, 1920, 4159, 2564, 4329, 10449, 1942, 6581, 2005, 3001, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
+{"id": "590bfb302940", "text": "They added that poly-pharmacy was common within the health system and that drug interaction was more likely to cause some of the side effects that the patients complain about.", "entities": [], "input_ids": [2, 2611, 4057, 1988, 4286, 17, 14429, 1982, 3059, 2651, 1920, 2436, 2433, 1930, 1988, 2838, 2835, 1982, 2253, 3205, 1942, 3936, 2673, 1927, 1920, 4159, 2564, 1988, 1920, 2132, 6581, 2005, 3001, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
+{"id": "f9bce99c9651", "text": "The participants reported that this was common with patients who suffered side effects due to non-adherence to the dosing regimen because they were likely to be verbally abused by the health workers.", "entities": [], "input_ids": [2, 1920, 3003, 2568, 1988, 2052, 1982, 3059, 1956, 2132, 2746, 13949, 4159, 2564, 2810, 1942, 2447, 17, 7015, 1942, 1920, 10654, 8607, 2882, 2611, 1985, 3205, 1942, 1998, 10011, 1954, 7764, 1007, 2007, 1920, 2436, 7066, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
+{"id": "1e517fd4e359", "text": "The health professionals explained that some malaria patients only initiate treatment when the condition is severe and that this was responsible for some of the side effects and not necessarily the ACT.", "entities": [], "input_ids": [2, 1920, 2436, 9229, 6094, 1988, 2673, 7505, 2132, 2444, 11051, 2311, 2469, 1920, 2625, 1977, 4010, 1930, 1988, 2052, 1982, 5061, 1958, 2673, 1927, 1920, 4159, 2564, 1930, 2084, 9409, 1920, 4033, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
+{"id": "5fdbbc32789e", "text": "Patient-related factorsPatients are usually not motivated to come back and report adverse events especially if the side effects are those already known to be associated with the drug.", "entities": [], "input_ids": [2, 2774, 17, 2712, 2790, 15050, 2032, 5394, 2084, 15531, 1942, 10449, 3231, 1930, 3809, 5246, 3916, 4369, 2647, 1920, 4159, 2564, 2032, 2690, 6064, 3171, 1942, 1998, 2458, 1956, 1920, 2838, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
+{"id": "c4ca791e4fc6", "text": "Of 439 participants that received medicines from the dispensary, 6% received information about possible side effects of medicines from their HCW.Table 2Persons or institutions to whom the participants reported or would report an adverse drug reaction (ADR).", "entities": [], "input_ids": [2, 1927, 3941, 1026, 3003, 1988, 4004, 12864, 2037, 1920, 13404, 2141, 16, 26, 9, 4004, 2988, 3001, 3216, 4159, 2564, 1927, 12864, 2037, 2310, 4387, 1018, 18, 2545, 21981, 12269, 1036, 2014, 10977, 1942, 8566, 1920, 3003, 2568, 2014, 2962, 3809, 1925, 5246, 2838, 3227, 12, 17645, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
+{"id": "1ca1af282bf4", "text": "The health professionals were selected to share their experiences on the side effects of ACT and the factors affecting side effects reporting.", "entities": [], "input_ids": [2, 1920, 2436, 9229, 1985, 3790, 1942, 7948, 2310, 7651, 1990, 1920, 4159, 2564, 1927, 4033, 1930, 1920, 2790, 7359, 4159, 2564, 6605, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
+{"id": "3e0bbeefe10e", "text": "ConclusionThe key factors responsible for the inability of patients to report side effects from using ACT are lack of health education, attitude of some patients and the unpleasant behaviour of some health workers towards patients at the health facilities.", "entities": [], "input_ids": [2, 4180, 20536, 3834, 2790, 5061, 1958, 1920, 11752, 1927, 2132, 1942, 3809, 4159, 2564, 2037, 2193, 4033, 2032, 3630, 1927, 2436, 4767, 16, 14204, 1927, 2673, 2132, 1930, 1920, 25429, 6270, 1927, 2673, 2436, 7066, 5681, 2132, 2019, 1920, 2436, 8774, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
+{"id": "a145da3c7c61", "text": "A 38-year old health worker had this to say on the issue:“Well, some patients vomit and there is dizziness as well, but it is the dizziness and the vomiting that I have heard a lot of people complained about.", "entities": [{"start": 2, "end": 28, "label": "PATIENT_DEMO", "text": "38-year old health worker"}, {"start": 77, "end": 84, "label": "ADR", "text": "vomit"}, {"start": 97, "end": 106, "label": "ADR", "text": "dizziness"}, {"start": 130, "end": 139, "label": "ADR", "text": "dizziness"}, {"start": 148, "end": 156, "label": "ADR", "text": "vomiting"}], "input_ids": [2, 43, 3738, 17, 2476, 4156, 2436, 16187, 2430, 2052, 1942, 12471, 1990, 1920, 6972, 30, 236, 2486, 16, 2673, 2132, 13463, 1932, 1930, 2276, 1977, 24009, 1966, 2486, 16, 2308, 2176, 1977, 1920, 24009, 1930, 1920, 13954, 1988, 51, 2162, 22938, 43, 12026, 1927, 4329, 26199, 3001, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 7, 8, 8, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
+{"id": "f1698bc5c842", "text": "Despite the fact that some level of health education has been given to patients by health workers on the use of ACT and how to prevent malaria, there is a need for health workers to specifically educate patients on the side effects of ACT.It is, therefore, recommended that intensive and continued education should be incorporated into the routine health care activities.", "entities": [], "input_ids": [2, 4281, 1920, 2371, 1988, 2673, 2237, 1927, 2436, 4767, 2258, 2252, 3258, 1942, 2132, 2007, 2436, 7066, 1990, 1920, 2485, 1927, 4033, 1930, 2307, 1942, 4625, 7505, 16, 2276, 1977, 43, 2942, 1958, 2436, 7066, 1942, 4475, 4066, 2010, 2132, 1990, 1920, 4159, 2564, 1927, 4033, 18, 2176, 1977, 16, 2955, 16, 6198, 1988, 8100, 1930, 7583, 4767, 3066, 1998, 8800, 2460, 1920, 7341, 2436, 2859, 4209, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "qualitative_interview"}
+{"id": "6f1aa3760968", "text": "Although oculogyric crisis is mostly drug-induced, it can be seen in hereditary and sporadic movement disorders and disorders related to focal brain lesions.", "entities": [{"start": 9, "end": 26, "label": "ADR", "text": "oculogyric crisis"}], "input_ids": [2, 2876, 25669, 2021, 19872, 17263, 1977, 6969, 2838, 17, 2719, 16, 2176, 2112, 1998, 3945, 1922, 16321, 1930, 13088, 5829, 4414, 1930, 4414, 2712, 1942, 8083, 3068, 4518, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
+{"id": "9587ecf2481a", "text": "He was admitted at a peripheral hospital at the onset of his symptoms for three days and was managed as a case of severe anaemia secondary to intravascular haemolysis from naphthalene containing herbal preparation.", "entities": [{"start": 120, "end": 128, "label": "ADR", "text": "anaemia"}, {"start": 141, "end": 166, "label": "ADR", "text": "intravascular haemolysis"}, {"start": 171, "end": 184, "label": "DRUG", "text": "naphthalene"}], "input_ids": [2, 2234, 1982, 9723, 2019, 43, 5009, 3461, 2019, 1920, 4727, 1927, 4167, 3601, 1958, 2559, 3000, 1930, 1982, 11155, 1966, 43, 3087, 1927, 4010, 19682, 4067, 1942, 19871, 7105, 6892, 2037, 26795, 2880, 3165, 15953, 6040, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 4, 4, 4, 0, 2, 2, 0, 0, 0, 0, -100], "source_type": "case_report"}
+{"id": "b2efd0327c0d", "text": "Wyllie et al. reported that versive seizures can mimic oculogyric crisis, but they are associated with an alteration of consciousness and should be excluded with an electroencephalogram [9].", "entities": [], "input_ids": [2, 24622, 11560, 2621, 2140, 1969, 18, 2568, 1988, 3162, 2320, 10060, 2112, 10223, 25669, 2021, 19872, 17263, 16, 2308, 2611, 2032, 2458, 1956, 1925, 10076, 1927, 16897, 1930, 3066, 1998, 5450, 1956, 1925, 21657, 7539, 37, 29, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
+{"id": "16d2295082d0", "text": "Our patient presented with hypotension which increased his risk of AKI.", "entities": [], "input_ids": [2, 2342, 2774, 3549, 1956, 16453, 2154, 2502, 4167, 2565, 1927, 12637, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
+{"id": "1d23490f06db", "text": "ADRs can also be a side effect of other medications, such as antiemetic, antipsychotic, antidepressant, antiepileptic, and antimalarial medications, which produce ADRs due to dopaminergic-cholinergic imbalance in the basal ganglia [3].", "entities": [], "input_ids": [2, 28863, 2112, 2222, 1998, 43, 4159, 2495, 1927, 2303, 7719, 16, 2427, 1966, 2246, 17800, 2002, 16, 17581, 16, 14183, 16, 29132, 16, 1930, 27290, 7719, 16, 2154, 5074, 28863, 2810, 1942, 12214, 17, 13908, 14093, 1922, 1920, 5342, 13086, 37, 23, 39, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
+{"id": "119eb1c0efe4", "text": "Aluminium toxicity has been well described in literature as a cause of encephalopathy, osteomalacia and microcytic anaemia especially in patients who have been on chronic dialysis.", "entities": [{"start": 0, "end": 10, "label": "DRUG", "text": "Aluminium"}, {"start": 70, "end": 85, "label": "ADR", "text": "encephalopathy"}, {"start": 87, "end": 99, "label": "ADR", "text": "osteomalacia"}, {"start": 104, "end": 123, "label": "ADR", "text": "microcytic anaemia"}, {"start": 136, "end": 180, "label": "PATIENT_DEMO", "text": "patients who have been on chronic dialysis."}], "input_ids": [2, 30094, 5532, 2258, 2252, 2486, 2910, 1922, 4431, 1966, 43, 3936, 1927, 19393, 16, 4416, 4229, 20243, 1930, 10572, 4274, 19682, 4369, 1922, 2132, 2746, 2162, 2252, 1990, 3724, 9787, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 3, 4, 4, 0, 3, 4, 4, 0, 0, 8, 8, 8, 8, 8, 8, 8, 8, -100], "source_type": "case_report"}
+{"id": "a0b0cc7b5c67", "text": "The management of drug-induced oculogyric crisis includes discontinuation or, if not possible, reducing the dose of the opposing agent.", "entities": [{"start": 31, "end": 48, "label": "ADR", "text": "oculogyric crisis"}], "input_ids": [2, 1920, 4280, 1927, 2838, 17, 2719, 25669, 2021, 19872, 17263, 5921, 14775, 2014, 16, 2647, 2084, 3216, 16, 5526, 1920, 3253, 1927, 1920, 17218, 5899, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "case_report"}
+{"id": "2a738f5c7200", "text": "7 DRUGLENS ISSUE 5 Hyoscine butylbromide (Buscopan) is indicated for acute muscular spasm including renal or biliary colic, in radiology for differential diagnosis of obstruction and to reduce spasm and pain in pyelography, and in other diagnostic procedures where spasm may be a problem.", "entities": [{"start": 19, "end": 40, "label": "DRUG", "text": "Hyoscine butylbromide"}, {"start": 42, "end": 50, "label": "DRUG", "text": "Buscopan"}], "input_ids": [2, 27, 2838, 15253, 1036, 6972, 25, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 12, 11730, 2972, 1928, 13, 1977, 3391, 1958, 3939, 12330, 24431, 2710, 4604, 2014, 13210, 5178, 1030, 16, 1922, 19528, 1958, 5611, 3574, 1927, 10849, 1930, 1942, 4412, 24431, 1930, 3594, 1922, 6085, 1938, 3796, 16, 1930, 1922, 2303, 4785, 4869, 2597, 24431, 2278, 1998, 43, 4915, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
+{"id": "f614b569df77", "text": "SPONTANEOUS REPORTING FOR 2021 Figure 1: Number of reports received from 2016-2021 Figure 2: Gender distribution of patients who had adverse reactions An analysis of the 1,333 adverse reaction reports showed that 768(57.6%) of those who had the reaction were females and 476 (35.7%) were males, the gender for the remaining 89 (6.7%) was not stated (refer to figure 2).", "entities": [{"start": 259, "end": 267, "label": "PATIENT_DEMO", "text": "females"}, {"start": 288, "end": 293, "label": "PATIENT_DEMO", "text": "males"}], "input_ids": [2, 6242, 6605, 1958, 17401, 1009, 2292, 21, 30, 2529, 1927, 4710, 4004, 2037, 4759, 17, 17401, 1009, 2292, 22, 30, 5125, 3282, 1927, 2132, 2746, 2430, 5246, 5298, 1925, 2333, 1927, 1920, 21, 16, 23142, 5246, 3227, 4710, 2594, 1988, 5439, 1025, 12, 4786, 18, 26, 9, 13, 1927, 2690, 2746, 2430, 1920, 3227, 1985, 5027, 1930, 4261, 1016, 12, 3259, 18, 27, 9, 13, 1985, 5129, 16, 1920, 5125, 1958, 1920, 5719, 5792, 12, 26, 18, 27, 9, 13, 1982, 2084, 9662, 12, 3333, 1942, 2292, 22, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
+{"id": "b65c4fbf1a99", "text": "11 Crystallization and Discoloration of Paracetamol 100mg IV Public Statement on the Withdrawal of Johnson and Johnson Brand of Baby Talcum Powder from North American Market Rigorous Quality Control Laboratory analysis to verify that indeed the talc-containing powders submitted do not contain asbestos.", "entities": [{"start": 40, "end": 51, "label": "DRUG", "text": "Paracetamol"}, {"start": 98, "end": 119, "label": "DRUG", "text": "Johnson and Johnson"}, {"start": 127, "end": 147, "label": "DRUG", "text": "Baby Talcum Powder"}], "input_ids": [2, 2513, 15416, 1930, 2863, 18778, 1943, 1927, 27021, 2813, 9759, 4370, 4462, 12977, 1990, 1920, 9594, 1927, 13890, 1930, 13890, 17154, 1927, 16099, 11571, 18021, 1035, 10201, 2037, 6873, 5339, 10878, 16372, 3455, 2285, 4542, 2333, 1942, 10491, 1988, 5087, 1920, 11571, 1030, 17, 3165, 25019, 10568, 2608, 2084, 5531, 24453, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
+{"id": "0fcbbf4189fb", "text": "Hyoscine butylbromide given intravenously or intramuscularly is indicated in acute muscular spasm, as in renal or biliary colic; in radiology for differential diagnosis of obstruction and to reduce spasm and pain in pyelography; and in other diagnostic procedures where spasm may be a problem (eg, gastroduodenal endoscopy).Hyoscine butylbromide injection can cause adverse effects including tachycardia, hypotension, and anaphylaxis.", "entities": [{"start": 0, "end": 21, "label": "DRUG", "text": "Hyoscine butylbromide"}, {"start": 323, "end": 344, "label": "DRUG", "text": "Hyoscine butylbromide"}, {"start": 390, "end": 401, "label": "ADR", "text": "tachycardia"}, {"start": 403, "end": 414, "label": "ADR", "text": "hypotension"}, {"start": 420, "end": 431, "label": "ADR", "text": "anaphylaxis"}], "input_ids": [2, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 3258, 15132, 2014, 16774, 1954, 1977, 3391, 1922, 3939, 12330, 24431, 16, 1966, 1922, 4604, 2014, 13210, 5178, 1030, 31, 1922, 19528, 1958, 2137, 1871, 1959, 4905, 2086, 3574, 1927, 10849, 1930, 1942, 4412, 24431, 1930, 3594, 1922, 6085, 1938, 3796, 31, 1930, 1922, 2303, 4785, 4869, 2597, 24431, 2278, 1998, 43, 4915, 12, 7282, 16, 6858, 10015, 5215, 3163, 15228, 13, 18, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 4107, 2112, 3936, 5246, 47, 1871, 2284, 2710, 17397, 16, 16453, 16, 1930, 26726, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 3, 0, -100], "source_type": "fda_newsletter"}
+{"id": "29d79410b28a", "text": "Hyoscine butylbromide injection can cause serious adverse effects including tachycardia, hypotension, and anaphylaxis. 2.", "entities": [{"start": 0, "end": 21, "label": "DRUG", "text": "Hyoscine butylbromide"}, {"start": 75, "end": 86, "label": "ADR", "text": "tachycardia"}, {"start": 88, "end": 99, "label": "ADR", "text": "hypotension"}, {"start": 105, "end": 116, "label": "ADR", "text": "anaphylaxis"}], "input_ids": [2, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 4107, 2112, 3936, 7433, 5246, 47, 1871, 2284, 2710, 17397, 16, 16453, 16, 1930, 26726, 18, 22, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 3, 0, 0, 0, -100], "source_type": "fda_newsletter"}
+{"id": "e4e52541f0b4", "text": "Hydrochlorothiazide-containing medicines are used to treat hypertension, as well as cardiac and hepatic oedema, or chronic heart insufficiency.", "entities": [{"start": 0, "end": 19, "label": "DRUG", "text": "Hydrochlorothiazide"}], "input_ids": [2, 14369, 30354, 2261, 17, 3165, 12864, 2032, 2251, 1942, 2297, 5579, 16, 1966, 2486, 1966, 4435, 1930, 6095, 24110, 16, 2014, 3724, 4003, 1, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
+{"id": "b9188793ce3c", "text": "SGLT2 containing-medicines registered for use in Ghana are Forxiga (Dapagliflozin) tablets, Invokana (Canagli flozin) tablets and Vokanamet (Canagliflozin and Metformin hydrochloride) tablets.", "entities": [{"start": 58, "end": 66, "label": "DRUG", "text": "Forxiga"}, {"start": 68, "end": 80, "label": "DRUG", "text": "Dapagliflozin"}, {"start": 91, "end": 100, "label": "DRUG", "text": "Invokana"}, {"start": 101, "end": 114, "label": "DRUG", "text": "Canagli flozin"}, {"start": 127, "end": 137, "label": "DRUG", "text": "Vokanamet"}, {"start": 139, "end": 151, "label": "DRUG", "text": "Canagliflozin"}, {"start": 156, "end": 179, "label": "DRUG", "text": "Metformin hydrochloride"}], "input_ids": [2, 24482, 12904, 3165, 17, 12864, 10012, 1958, 2485, 1922, 20685, 2032, 1958, 18068, 4223, 12, 8243, 15915, 1033, 1501, 25257, 13, 16576, 16, 2269, 22526, 2175, 12, 2112, 15915, 1033, 959, 25257, 13, 16576, 1930, 9805, 7640, 12253, 1946, 12, 2112, 15915, 1033, 1501, 25257, 1930, 11885, 16675, 13, 16576, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 1, 2, 2, 2, 2, 0, 0, 0, 1, 2, 2, 0, 1, 2, 2, 2, 2, 0, 0, 0, 2, 2, 2, 2, 0, 1, 2, 2, 2, 2, 0, 1, 2, 0, 0, 0, -100], "source_type": "fda_newsletter"}
+{"id": "1c25b9a3737b", "text": "Objective: Objective of this study is to describe the pattern of stimulated spontaneous adverse drug reaction (ADR) reports received from healthcare professionals for SARS-CoV-2 positive patients in Ghana and lessons learnt particularly for lowand middle-income countries.", "entities": [], "input_ids": [2, 4470, 30, 4470, 1927, 2052, 2161, 1977, 1942, 5993, 1920, 3114, 1927, 5449, 6242, 5246, 2838, 3227, 12, 17645, 13, 4710, 4004, 2037, 5841, 9229, 1958, 20466, 17, 6083, 17, 22, 2843, 2132, 1922, 20685, 1930, 20789, 12048, 1031, 4443, 1958, 2330, 2153, 5576, 17, 6793, 5085, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
+{"id": "a38aae17fd7e", "text": "The conclusion was based on the fact that FDA has not received any adverse reaction report to gentian violet use in humans and there is no evidence from the literature that gentian violet can cause cancer in humans.", "entities": [], "input_ids": [2, 1920, 4180, 1982, 2454, 1990, 1920, 2371, 1988, 11394, 2258, 2084, 4004, 2967, 5246, 3227, 3809, 1942, 11994, 3122, 16917, 2485, 1922, 5209, 1930, 2276, 1977, 2239, 3095, 2037, 1920, 4431, 1988, 11994, 3122, 16917, 2112, 3936, 2539, 1922, 5209, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
+{"id": "0ee3e23d7b2e", "text": "The most commonly reported AEFIs for the three vaccines were headache, fever, chills, pain at injection site and body pains which resolved within a day or two.", "entities": [{"start": 61, "end": 69, "label": "ADR", "text": "headache"}, {"start": 71, "end": 76, "label": "ADR", "text": "fever"}, {"start": 78, "end": 84, "label": "ADR", "text": "chills"}, {"start": 86, "end": 109, "label": "ADR", "text": "pain at injection site"}, {"start": 112, "end": 123, "label": "ADR", "text": "body pains"}], "input_ids": [2, 1920, 2501, 5384, 2568, 10194, 19894, 1036, 1958, 1920, 2559, 9375, 1985, 12187, 16, 9087, 16, 7368, 11560, 1036, 16, 3594, 2019, 4107, 3200, 1930, 3362, 3594, 1036, 2154, 8397, 2651, 43, 3007, 2014, 2288, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 3, 4, 4, 0, 3, 4, 4, 4, 0, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
+{"id": "094d81e53d99", "text": "Hyoscine butylbromide injection remains contraindi cated in patients with tachycardia.", "entities": [{"start": 0, "end": 21, "label": "DRUG", "text": "Hyoscine butylbromide"}, {"start": 59, "end": 85, "label": "PATIENT_DEMO", "text": "patients with tachycardia"}], "input_ids": [2, 4527, 17413, 2912, 16936, 18474, 16408, 1021, 4107, 4497, 17825, 1033, 3115, 1919, 1922, 2132, 1956, 17397, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 1, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 8, 8, 8, 0, -100], "source_type": "fda_newsletter"}
+{"id": "b2b6a6e755a8", "text": "All the reports were classified as nonserious reports and did not lead to any major reviews in policy. 8 Below is the list of signals identified by the FDA in 2020 through the spontaneous adverse reaction reporting system and actions taken to protect patients.", "entities": [], "input_ids": [2, 2136, 1920, 4710, 1985, 5947, 1966, 6771, 18842, 2080, 4710, 1930, 2811, 2084, 2949, 1942, 2967, 3044, 8617, 1922, 7299, 18, 28, 4535, 1977, 1920, 6069, 1927, 4771, 2899, 2007, 1920, 11394, 1922, 22656, 2596, 1920, 6242, 5246, 3227, 6605, 2433, 1930, 7728, 4208, 1942, 9145, 2132, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
+{"id": "19f454e5d635", "text": "Advice to patients and healthcare professionals: Patients • Seek medical attention immediately if you experience any symptoms of tenderness, redness, or swellng of the genitals or the area from the genitals back to therectum, and have a fever above 38oC or a general feeling of being unwell.", "entities": [{"start": 128, "end": 139, "label": "ADR", "text": "tenderness"}, {"start": 140, "end": 148, "label": "ADR", "text": "redness"}, {"start": 152, "end": 176, "label": "ADR", "text": "swellng of the genitals"}, {"start": 237, "end": 243, "label": "ADR", "text": "fever"}, {"start": 258, "end": 291, "label": "ADR", "text": "general feeling of being unwell."}], "input_ids": [2, 12267, 1942, 2132, 1930, 5841, 9229, 30, 2132, 241, 7592, 3423, 4976, 6183, 2647, 6253, 4848, 2967, 3601, 1927, 25900, 16, 2312, 2971, 16, 2014, 9736, 11560, 2029, 1927, 1920, 13473, 1036, 2014, 1920, 3403, 2037, 1920, 13473, 1036, 3231, 1942, 2276, 2341, 1989, 16, 1930, 2162, 43, 9087, 3538, 3738, 1994, 2014, 43, 3335, 14452, 1927, 3301, 12620, 1992, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 4, 4, 0, 0, 4, 4, 4, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 4, 4, 4, 4, 4, 4, 4, -100], "source_type": "fda_newsletter"}
+{"id": "ce0eb84924bb", "text": "Secondly, improved stakeholder collaboration has been found most effective, as the recent opioid epidemic - abuse of codeine, tramadol and other prescription medicines continues to be one of the major challenges facing the youth in our country.", "entities": [{"start": 116, "end": 123, "label": "DRUG", "text": "codeine"}, {"start": 125, "end": 133, "label": "DRUG", "text": "tramadol"}, {"start": 222, "end": 227, "label": "PATIENT_DEMO", "text": "youth"}], "input_ids": [2, 14158, 16, 4305, 27185, 11670, 2258, 2252, 2435, 2501, 47, 1871, 2451, 16, 1966, 1920, 3505, 9384, 12107, 17, 7764, 1927, 7815, 2053, 16, 23179, 28280, 1930, 2303, 10524, 12864, 12455, 1942, 1998, 2340, 1927, 1920, 3044, 7321, 15424, 1920, 7925, 1922, 2342, 7722, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
+{"id": "506043309524", "text": "Community pharmacies that volunteered to support this initiative were branded by the FDA as “Patient Safety Centres” with the responsibility to educate patients on how to identify side effects of medicine and vaccines and to report these to the FDA.", "entities": [], "input_ids": [2, 4413, 25843, 1988, 19921, 1919, 1942, 3373, 2052, 13690, 1985, 17154, 1919, 2007, 1920, 11394, 1966, 236, 2774, 5407, 13152, 237, 1956, 1920, 12205, 1942, 4066, 2010, 2132, 1990, 2307, 1942, 3512, 4159, 2564, 1927, 5380, 1930, 9375, 1930, 1942, 3809, 2144, 1942, 1920, 11394, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_newsletter"}
+{"id": "c1ade4ffdef9", "text": "Causality assessment of Adverse Drug Reaction (ADR) reports presented to the TAC by the Authority. d.", "entities": [], "input_ids": [2, 19140, 4076, 1927, 5246, 2838, 3227, 12, 17645, 13, 4710, 3549, 1942, 1920, 9214, 2007, 1920, 18791, 18, 46, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
+{"id": "95a1602cdf2b", "text": "Guideline on Reporting Adverse Drug Reactions FDA/SMD/GDL - 01/05 Page 10 of 28 “Risk Management Plan” A systematic approach and set of pharmacovigilance activities and interventions designed to identify, characterize, prevent or minimize risks relating to medical products, and the assessment of effectiveness of those interventions and how these risks will be communicated to the Authority and the general population. “Serious Adverse Drug Reaction or Adverse Event” A serious adverse event or reaction is any untoward medical occurrence that at any dose: • Results in death • Is life threatening • Requires inpatient hospitalisation or results in prolongation of existing hospitalisation; • Results in persistent or significant disability/incapacity; • Is a congenital anomaly/birth defect; • Is a medically important event or reaction. (NOTE: The term \"life-threatening\" in the definition of \"serious\" refers to an event/reaction in which the patient was at risk of death at the time of the event/reaction; it does not refer to an event/ reaction which hypothetically might have caused death if it were more severe); Medical and scientific judgment should be exercised in deciding whether other situations should be considered serious such as important medical events that might not be immediately life-threatening or result in death or hospitalisation but might jeopardise the patient or might require intervention to prevent one of the other outcomes listed in the definition above.", "entities": [], "input_ids": [2, 12954, 1990, 6605, 5246, 2838, 5298, 11394, 19, 23274, 19, 7113, 1024, 17, 3287, 19, 2914, 7178, 2119, 1927, 3158, 236, 2565, 4280, 4720, 237, 43, 5614, 2998, 1930, 2735, 1927, 4602, 25210, 6121, 17576, 1972, 4209, 1930, 4984, 4609, 1942, 3512, 16, 8063, 16, 4625, 2014, 9491, 7481, 13056, 1942, 3423, 4461, 16, 1930, 1920, 4076, 1927, 6001, 1927, 2690, 4984, 1930, 2307, 2144, 7481, 2832, 1998, 18606, 1007, 1942, 1920, 18791, 1930, 1920, 3335, 2973, 18, 236, 7433, 5246, 2838, 3227, 2014, 5246, 4817, 237, 43, 7433, 5246, 4817, 2014, 3227, 1977, 2967, 18472, 20572, 8544, 3423, 6564, 1988, 2019, 2967, 3253, 30, 241, 2274, 1922, 3539, 241, 1977, 3308, 13281, 241, 5474, 12037, 26185, 2014, 2274, 1922, 20334, 1927, 6124, 26185, 31, 241, 2274, 1922, 7733, 2014, 2228, 8015, 19, 22689, 28278, 3145, 31, 241, 1977, 43, 9901, 20950, 19, 5043, 7374, 31, 241, 1977, 43, 19971, 2715, 4817, 2014, 3227, 18, 12, 4725, 30, 1920, 2576, 6, 3308, 17, 13281, 6, 1922, 1920, 6600, 1927, 6, 7433, 6, 11238, 1942, 1925, 4817, 19, 3227, 1922, 2154, 1920, 2774, 1982, 2019, 2565, 1927, 3539, 2019, 1920, 2367, 1927, 1920, 4817, 19, 3227, 31, 2176, 3731, 2084, 3333, 1942, 1925, 4817, 19, 3227, 2154, 15148, 1954, 3284, 2162, 4189, 3539, 2647, 2176, 1985, 2253, 4010, 13, 31, 3423, 1930, 5478, 17449, 3066, 1998, 27776, 1922, 25844, 3053, 2303, 9370, 3066, 1998, 3311, 7433, 2427, 1966, 2715, 3423, 3916, 1988, 3284, 2084, 1998, 6183, 3308, 17, 13281, 2014, 3211, 1922, 3539, 2014, 26185, 2308, 3284, 8988, 23091, 15783, 1021, 1920, 2774, 2014, 3284, 4350, 3280, 1942, 4625, 2340, 1927, 1920, 2303, 3685, 7663, 1922, 1920, 6600, 3538, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
+{"id": "290c60949728", "text": "Guideline on Reporting Adverse Drug Reactions FDA/SMD/GDL - 01/05 Page 11 of 28 medicines and which is not derived from a study or any organized data collection systems where adverse event reporting is actively sought. “Unexpected Adverse Reaction” An unexpected adverse reaction is one in which the nature, specificity, severity and outcome is not consistent with the applicable product information (i.e., with the approved package inserts for registered medicines, or the investigator’s brochure or other product information for unregistered medicines.", "entities": [], "input_ids": [2, 12954, 1990, 6605, 5246, 2838, 5298, 11394, 19, 23274, 19, 7113, 1024, 17, 3287, 19, 2914, 7178, 2513, 1927, 3158, 12864, 1930, 2154, 1977, 2084, 3595, 2037, 43, 2161, 2014, 2967, 11275, 2230, 4957, 3771, 2597, 5246, 4817, 6605, 1977, 11182, 8758, 18, 236, 9892, 5246, 3227, 237, 1925, 9892, 5246, 3227, 1977, 2340, 1922, 2154, 1920, 4899, 16, 4896, 16, 5155, 1930, 3924, 1977, 2084, 3499, 1956, 1920, 10045, 4863, 2988, 12, 51, 18, 47, 18, 16, 1956, 1920, 4871, 8511, 17520, 1958, 10012, 12864, 16, 2014, 1920, 12687, 234, 61, 4188, 2072, 2027, 2014, 2303, 4863, 2988, 1958, 13497, 6121, 2156, 7752, 12864, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
+{"id": "a887f8cbde8f", "text": "All spontaneous reports are, therefore, suspected adverse drug reactions. “Adverse Event (or adverse experience)” “Adverse event/experience” is any untoward medical occurrence in a patient or clinical trial subject administered a product that may present during treatment with a medicine but which does not necessarily have a causal relationship with this treatment. “Adverse Events Following Immunization (AEFI)” An Adverse Event Following Immunization is any untoward medical occurrence which follows immunization and which does not necessarily have a causal relationship with the usage of the vaccine.", "entities": [], "input_ids": [2, 2136, 6242, 4710, 2032, 16, 2955, 16, 9407, 5246, 2838, 5298, 18, 236, 5246, 4817, 12, 2014, 5246, 4848, 13, 237, 236, 5246, 4817, 19, 4848, 237, 1977, 2967, 18472, 20572, 8544, 3423, 6564, 1922, 43, 2774, 2014, 2535, 3046, 5198, 5254, 43, 4863, 1988, 2278, 2481, 2409, 2311, 1956, 43, 5380, 2308, 2154, 3731, 2084, 9409, 2162, 43, 9263, 3303, 1956, 2052, 2311, 18, 236, 5246, 3916, 2894, 10139, 12, 10194, 19894, 13, 237, 1925, 5246, 4817, 2894, 10139, 1977, 2967, 18472, 20572, 8544, 3423, 6564, 2154, 6052, 10139, 1930, 2154, 3731, 2084, 9409, 2162, 43, 9263, 3303, 1956, 1920, 10070, 1927, 1920, 5955, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "fda_guideline"}
+{"id": "d3576317b790", "text": "Five potential safety concerns were identified under the period under review: anaemia (5 reports), jaundice (4 reports), aggression (2 reports), difficulty breathing (2 reports), and thigh pain (1 report).", "entities": [{"start": 78, "end": 85, "label": "ADR", "text": "anaemia"}, {"start": 99, "end": 107, "label": "ADR", "text": "jaundice"}, {"start": 120, "end": 131, "label": "ADR", "text": "aggression"}, {"start": 145, "end": 165, "label": "ADR", "text": "difficulty breathing"}, {"start": 182, "end": 193, "label": "ADR", "text": "thigh pain"}], "input_ids": [2, 3628, 2889, 5407, 8103, 1985, 2899, 2441, 1920, 3047, 2441, 3043, 30, 19682, 12, 25, 4710, 13, 16, 25314, 12, 24, 4710, 13, 16, 13116, 12, 22, 4710, 13, 16, 8791, 11995, 12, 22, 4710, 13, 16, 1930, 19125, 3594, 12, 21, 3809, 13, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 0, 0, -100], "source_type": "fda_annual_report"}
+{"id": "2b7ae6c39be4", "text": "Up to 88.9% (32/36) were drug-related, covering a wide range of groups of medications.", "entities": [], "input_ids": [2, 2353, 1942, 5744, 18, 29, 9, 12, 3323, 19, 3480, 13, 1985, 2838, 17, 2712, 16, 12275, 43, 4743, 3109, 1927, 2671, 1927, 7719, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
+{"id": "fa2cc2dc54ae", "text": "All the 35 ADR reports were assessed for causality as indicated in Fig 6 with the majority (54.3%) graded as ‘Possible’.10.1371/journal.pone.0291482.g006Fig 6Causality assessment of ADR reports from the Ho Municipality, 2015–2019.While the reports from the Ho Municipality did not have a direct influence on the risk of ADR concerns that were discovered throughout the reporting period, when combined with other information, a signal was formed about the widespread abuse of cough syrups containing codeine.", "entities": [{"start": 498, "end": 506, "label": "DRUG", "text": "codeine"}], "input_ids": [2, 2136, 1920, 3259, 17645, 4710, 1985, 3683, 1958, 19140, 1966, 3391, 1922, 2095, 26, 1956, 1920, 4827, 12, 4584, 18, 23, 9, 13, 13175, 1966, 233, 3216, 234, 18, 2119, 18, 28687, 19, 5776, 18, 15065, 1021, 18, 21310, 23026, 1028, 18, 17287, 14265, 9344, 10784, 26973, 5951, 4076, 1927, 17645, 4710, 2037, 1920, 6673, 26895, 16, 4299, 229, 14064, 18, 2679, 1920, 4710, 2037, 1920, 6673, 26895, 2811, 2084, 2162, 43, 3083, 4039, 1990, 1920, 2565, 1927, 17645, 8103, 1988, 1985, 8117, 5264, 1920, 6605, 3047, 16, 2469, 4252, 1956, 2303, 2988, 16, 43, 2733, 1982, 5333, 3001, 1920, 9360, 7764, 1927, 13588, 11458, 25372, 3165, 7815, 2053, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, -100], "source_type": "surveillance_evaluation"}
+{"id": "28991a0ea539", "text": "Feedback on causality assessment is sent through the same channel of reporting to the primary reporter and the patient or general public.", "entities": [], "input_ids": [2, 6491, 1990, 19140, 4076, 1977, 8437, 2596, 1920, 2841, 4999, 1927, 6605, 1942, 1920, 3065, 6734, 1930, 1920, 2774, 2014, 3335, 4462, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}
+{"id": "a1c3611226b2", "text": "A suspected ADR that was documented by the healthcare provider or patient and sent to the MHD but did not end up in NPC is not considered reported.", "entities": [], "input_ids": [2, 43, 9407, 17645, 1988, 1982, 6974, 2007, 1920, 5841, 10989, 2014, 2774, 1930, 8437, 1942, 1920, 5146, 1007, 2308, 2811, 2084, 2482, 2353, 1922, 13585, 1977, 2084, 3311, 2568, 18, 3], "attention_mask": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1], "token_type_ids": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], "labels": [-100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100], "source_type": "surveillance_evaluation"}